POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Elgaaen, Bente Vilming ^a   Haug, Kari Bente Foss ^a   Wang, Junbai ^a   Olstad, Ole Kristoffer ^a   Fortunati, Dario ^a   Onsrud, Mathias ^a,b   Staff, Anne Cathrine ^a,b   Sauer, Torill ^a,b   Gautvik, Kaare M ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; BIOLOGICAL MARKER; CHROMOSOME 9 OPEN READING FRAME 89; DNA POLYMERASE DELTA 2 SMALL SUBUNIT; KILLER SPECIFIC SECRETORY PROTEIN OF 37; MESSENGER RNA; NUCLEOLAR PROTEIN FAMILY A MEMBER 2; PROTEIN ASSOCIATED WITH TOLL LIKE RECEPTOR 4A; TUMOR PROTEIN; UNCLASSIFIED DRUG; DNA DIRECTED DNA POLYMERASE GAMMA; KSP37 PROTEIN, HUMAN; PLASMA PROTEIN;

ADVANCED CANCER; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYSTADENOCARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR WEIGHT; OUTCOME ASSESSMENT; OVARY CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; AGED; GENETICS; METABOLISM; NEOPLASM; OVARIAN EPITHELIAL CANCER; OVARY CYST; OVARY TUMOR;

AGED; BLOOD PROTEINS; CYSTADENOCARCINOMA, SEROUS; DNA POLYMERASE III; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OUTCOME ASSESSMENT (HEALTH CARE); OVARIAN CYSTS; OVARIAN NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78149491705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013837     Document Type: Article

References (30)

1. Bray F (2009) Cancer Registry of Norway. Oslo: Cancer in Norway 2008 - Cancer incidence, mortality, survival and prevalence in Norway.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
3. Farley J, Ozbun LL, Birrer MJ (2008) Genomic analysis of epithelial ovarian cancer. Cell Res 18: 538-548.
4. Naora H (2007) The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms. Expert Rev Mol Med 9: 1-12.
5. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22: 255-288.
6. Landen CN, Jr., Birrer MJ, Sood AK (2008) Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 26: 995-1005.
7. Prat J (2009) Ovarian serous and mucinous epithelial-stromal tumors. In: Robboy's pathology of the female reproductive tract.
8. Shih I, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164: 1511-1518.
9. Bell DA (2005) Origins and molecular pathology of ovarian cancer. Mod Pathol 18 Suppl 2: S19-S32.
10. Meinhold-Heerlein I, Bauerschlag D, Hilpert F, Dimitrov P, Sapinoso LM, et al. (2005) Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 24: 1053-1065.
11. Chan WY, Cheung KK, Schorge JO, Huang LW, Welch WR, et al. (2000) Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol 156: 409-417.
12. Olstad OK, Gautvik VT, Reppe S, Rian E, Jemtland R, et al. (2003) Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning. Anticancer Res 23: 2201-2216.
13. Ogawa K, Tanaka K, Ishii A, Nakamura Y, Kondo S, et al. (2001) A novel serum protein that is selectively produced by cytotoxic lymphocytes. J Immunol 166: 6404-6412.
14. Pogacic V, Dragon F, Filipowicz W (2000) Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol 20: 9028-9040.
15. Battini R, Ferrari S, Kaczmarek L, Calabretta B, Chen ST, et al. (1987) Molecular cloning of a cDNA for a human ADP/ATP carrier which is growthregulated. J Biol Chem 262: 4355-4359.
16. Perez A, Leon A, Lee MY (2000) Characterization of the 59-flanking region of the gene encoding the 50 kDa subunit of human DNA polymerase delta. Biochim Biophys Acta 1493: 231-236.
17. Matsushima-Nishiu M, Unoki M, Ono K, Tsunoda T, Minaguchi T, et al. (2001) Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN. Cancer Res 61: 3741-3749.
18. Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, et al. (2009)Anetwork model of a cooperative genetic landscape in brain tumors. JAMA 302: 261-275.
19. Yamanaka R, Arao T, Yajima N, Tsuchiya N, Homma J, et al. (2006) Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene 25: 5994-6002.
20. Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS, et al. (2002) Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1: 53-62.
21. Sasaki R, Narisawa-Saito M, Yugawa T, Fujita M, Tashiro H, et al. (2009) Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes. Carcinogenesis 30: 423-431.
22. Okamura H, Katabuchi H (2005) Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis. Int Rev Cytol 242: 1-54.
23. Zorn KK, Jazaeri AA, Awtrey CS, Gardner GJ, Mok SC, et al. (2003) Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies. Clin Cancer Res 9: 4811-4818.
24. Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, et al. (2002) Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 62: 4722-4729.
25. Shimizu M, Nikaido T, Toki T, Shiozawa T, Fujii S (1999) Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas. Cancer 85: 669-677.
26. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
27. Wang J, Delabie J, Aasheim H, Smeland E, Myklebost O (2002) Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study. BMC Bioinformatics 3: 36.
28. Wang J (2007) A new framework for identifying combinatorial regulation of transcription factors: a case study of the yeast cell cycle. J Biomed Inform 40: 707-725.
29. Woo HN, Hong GS, Jun JI, Cho DH, Choi HW, et al. (2004) Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein. FEBS Lett 578: 239-244.
30. Wakabayashi Y, Kobayashi M, Akashi-Takamura S, Tanimura N, Konno K, et al. (2006) A protein associated with toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4. J Immunol 177: 1772-1779.